Published: 09/14/2026 | Author: Nikki Wisher

Overdose deaths fell across much of the United States from 2023 to 2024 and a new analysis finds the greatest progress in areas that treated the opioid crisis with multiple responses rather than one fix.

The study compares U.S. states with other countries. The pattern is consistent. Years of combined investment in naloxone and harm reduction distribution.

Opioids in States

The opioid crisis hit states including Ohio, New York, Maryland, Virginia and Missouri hard and all reported drops in overdose mortality. Sweden cut its drug death rate by roughly 25% since 2017. Scotland also continued to see deaths fall.

The progress remains fragile. Early 2025 data show an additional 70,000 American lives lost to overdose. In fact, some states and Scotland recorded upticks after a year of improvement. Drug overdose deaths rose 32% in Argentina and 21% in Brazil between 2023 and 2024 as synthetic opioids flooded those markets and social services were disrupted.

Driving the Change

The study looked at five overlapping strategies.

Naloxone tops the list. Maryland officials doubled naloxone distribution between 2021 and 2025, surpassing 460,000 doses and saw a major drop in overdose deaths. 

New York runs the nation’s first online portal offering free naloxone to every resident. They’ve shipped 390,000 kits since 2022. 

Ohio offers no-cost naloxone and stocks vending machines in prisons and at highway rest stops. 

Missouri centralized purchasing to drive down costs.

Fentanyl’s Role

Opioids are a class of drugs that includes prescription painkillers and illegal stuff on the streets. Many people who develop heroin addiction first misused prescription opioids. 

Fentanyl is 50x deadlier than heroin. Its presence in the drug supply is the leading driver of narcotic addiction deaths in the United States. 

No single factor explains the decline, but the drug supply itself is shifting. The analysis credits falling fentanyl potency, wider drug checking services and a move from injection to smoking among people who use drugs. An aging population of people who use drugs with lower tolerance after periods of reduced use also plays a role.

Harm Reduction Helps

Naloxone, sold under the brand name Narcan, reverses opioid overdose by restoring normal breathing. It has no potential for misuse and can be given safely even if opioids aren’t present. Emerging adulterants such as xylazine complicate overdoses because naloxone doesn’t reverse their effects. This makes calling 911 essential in every suspected overdose.

Drug checking tools work. Ohio legalized fentanyl test strips in 2023 and later decriminalized strips for emerging substances including xylazine, medetomidine and nitazenes. Delaware passed legislation covering the full range of harm reduction supplies. Maryland’s Rapid Analysis of Drugs program has processed thousands of drug samples to guide where prevention resources go.

The second major theme is expanded access to medication for opioid use disorders. The analysis calls Medicaid expansion to broaden coverage. Colorado grew its methadone clinics from to 54, while New York expanded methadone programs to 137, supported by mobile units. Maryland trains paramedics to administer buprenorphine on site.

Medication treats the medical side of opioid addiction. Peer support sustains a long recovery. Folks can look up Narcotics Anonymous meetings in their city and state daily in most communities. Regular meeting attendance is associated with stronger long-term recovery outcomes, and NA complements medication-based care rather than replacing it.

NA Remains a Top Option

Narcotics Anonymous meetings are free, require no insurance or referral and welcome anyone with a desire to stop using narcotics. Our browsable meeting finder tool for NA meetings will surface options by day and format.

Feel free to also dial 800-934-1582(Sponsored) to chat with an expert regarding free and confidential guidance.